State Policy: Virginia Delegate Files Ban on Prescription Commercial Data
Virginia Assembly Delegate, Mark D. Sickles (Dem., Springfield), a proponent of bringing investment in Bio Tech and Biosciences…
Author
Eli Lilly: Settles for 1.4 Billion, Now the Details
Eli Lilly agreed to pay $1.4 Billion to the U.S. government to settle criminal and civil cases surrounding the promotion of…
IOM: ACCME Testimony – IOM – Try Again
The ACCME does believe that an enhanced research enterprise can help ACCME meet its mission – but we are not sure that any…
State Policy: Texas introduces Two Transparency Bills “Everybody Loves…
”Everybody loves Transparency - this was the theme of a recent Dallas Morning News article outlining two transparency bills SB…
Grassley: GSK Avandia Email Report — Looking Over Your Shoulder
According to The Wall Street Journal, coming soon to your local newspaper is a report from Senator Grassley on e-mails his staff…
FDA: Issues Guidance on Journal Reprints
In a move that has many wondering where it came from (as it was not on the Bush list of priorities prior to leaving office),…
Health Care Reform: Kennedy Legacy to Speed Process
Senator Edward Kennedy’s health has transformed President-elect Barack Obama’s plan to reform national healthcare into a legacy…
FDA: Vytorin Scare a False Alarm
After a one-year safety review of Vytorin, the FDA announced that patients should stay on Vytorin therapy.
According to the FDA…
Massachusetts Physician Registry: MWE Unraveling the Web of Confusion
When you read the proposed regulations from Massachusetts, you get a headache trying to figure out how they will deal with the…
OIG Release Report on Clinical Investigators’ Financial Information
According to the OIG, the Food and Drug Administration (FDA) needs to do a better job in collecting and evaluating financial…